Adeline Siew, PhD


Adeline Siew is science editor for BioPharm International.


Characterizing Critical Quality Attributes in Biopharmaceutical Drug Development

Andrew Bulpin, head of Process Solutions, MilliporeSigma, shares insights on characterizing CQAs in biopharmaceutical development and the different tests that should be carried out when assessing an investigational drug.

Expression systems for the development of biosimilars

Andrew Bulpin, head of Process Solutions Strategic Marketing & Innovation at MilliporeSigma spoke with BioPharm International about the requirements of expression systems in biosimilar development.